Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | HBB | P68871 | 1/20 | 0.67 |
| ▸ | TK2 | O00142 | 2/20 | 0.65 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.64 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.64 |
| ▸ | NT5E | P21589 | 1/20 | 0.64 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.60 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.60 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.53 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5-Fluorouridine SCHEMBL329747 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL19901621 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL1682759 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL3385435 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL12174049 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL329381 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL17173362 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL11756887 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL21423048 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT | |
| 5-Fluorouridine SCHEMBL2584234 | 1.00 | PYGM (0.70) | PYGMLMNASMN1; SMN2TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630985-B1 | SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS | ARCTURUS THERAPEUTICS INC (US) | 2025-08-27 | — | — | EP | claimed |
| CN-110719954-B | Therapeutic agent for glycogen storage disease type III | 奥特吉尼克斯制药公司 | 2023-12-26 | — | — | CN | claimed |
| EP-3191114-B1 | OCCIDIOFUNGIN FORMULATIONS AND USES THEREOF | UNIV MISSISSIPPI STATE (US) | 2021-03-03 | — | — | EP | claimed |
| US-10247732-B2 | Materials and methods for diagnosing and predicting the course of prostate cancer | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2019-04-02 | — | — | US | claimed |
| EP-2488182-B1 | Treating neurotoxicity associated with combinations of 5-FU or its prodrugs and DPD inhibitors | ELION ONCOLOGY LLC (US) | 2017-07-19 | — | — | EP | claimed |
| EP-2476707-B1 | Self-cleaving ribozymes and uses thereof | CHILDREN'S MEDICAL CENTER CORP (US) | 2017-05-24 | — | — | EP | claimed |
| US-20170030916-A1 | MATERIALS AND METHODS FOR DIAGNOSING AND PREDICTING THE COURSE OF PROSTATE CANCER | UNIV INDIANA RES & TECH CORP (US) | 2017-02-02 | — | — | US | claimed |
| EP-2475674-B1 | PROBES COMPRISING FLUORESCENT ARTIFICIAL NUCLEOBASES AND USE THEREOF FOR DETECTION OF SINGLE BASE ALTERATION | HUMBOLDT UNIVERSITÄT ZU BERLIN (DE) | 2017-01-25 | — | — | EP | claimed |
| EP-2012799-B1 | METABOLICALLY STABLE ALKOXYALKYL ESTERS OF ANTIVIRAL OR ANTIPROLIFERATIVE PHOSPHONATES, NUCLEOSIDE PHOSPHONATES AND NUCLEOSIDE PHOSPHATES | CHIMERIX INC (US) | 2016-08-24 | — | — | EP | claimed |
| EP-2308885-B1 | Novel compounds and methods for therapy | GILEAD SCIENCES INC (US) | 2014-11-19 | — | — | EP | claimed |
| EP-0989847-A1 | ANTI-TUMORAL THERAPY AGENT | MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) | 2000-04-05 | — | — | EP | claimed |
| WO-1998055103-A9 | ANTI-TUMORAL THERAPY AGENT | MAX DELBRUECK CENTRUM (DE) | 1999-04-08 | — | — | WO | claimed |
| EP-0741740-B1 | METHOD OF PREPARING UNSYMMETRICAL PHOSPHORIC ACID DIESTERS AND SALTS | ROCHE DIAGNOSTICS GMBH (DE) | 1999-04-07 | — | — | EP | claimed |
| WO-1998055103-A1 | ANTI-TUMORAL THERAPY AGENT | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 1998-12-10 | — | — | WO | claimed |
| EP-0653439-A2 | Stabilized oligonucleotids and the use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-05-17 | — | — | EP | claimed |
| EP-0595133-A2 | Prodrugs, their preparation and use as medicaments | BEHRINGWERKE Aktiengesellschaft (DE) | 1994-05-04 | — | — | EP | claimed |
| EP-0262876-B1 | NUCLEOSIDE-PHOSPHOLIPID CONJUGATE | TOYO JOZO KABUSHIKI KAISHA (JP) | 1992-04-29 | — | — | EP | claimed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | claimed |
| US-5051499-A | Phosphatides as antitumor agents | TOYO JOZO KABUSHIKI KAISHA (JP) | 1991-09-24 | — | — | US | claimed |
| US-4797479-A | ANTITUMOR AGENTS, ANTICARCINOGENIC AGENTS | TOYO JOZO KABUSHIKI KAISHA (JP) | 1989-01-10 | — | — | US | claimed |